Future Healthcare 100 Unveils Six Prestigious Rankings and Awards, Bringing Together 1,000+ Unicorns and High-Potential Innovators to Explore Paths of Innovation
Over the seven years of VCBeat’s journey, venture capital and investment have remained one of our core keywords. From our initial rankings to the nascent formation of the Future Healthcare 100 Conference, and further to our core product ecosystem of “rankings + conference + reports,” venture capital and investment have become an increasingly indispensable component.The Future Healthcare 100, established in 2015, has to dateAlreadyOver 1,500Potential Innovative Companies Listed, with as many in 2019 aloneOver 500Innovative enterprises make the list.
A review of companies listed in previous years includes Allist, Biofourmis, Antengene, Gracell Biotechnologies, JD Health, Harbour BioMed, Jacobio Pharmaceuticals, Keymed Biosciences, Kintor Pharmaceutical, Konzen Medical, InnoCare Pharma, Peijia Medical, Frontier Biotechnologies, Sansure Biotech, SinoCellTech, I-Mab, Adagene, MicroPort CardioFlow, Luye Pharma Group, Yidu Cloud, WuXi Juno Therapeutics, and Zai Lab.22 companiesCompanies have gradually achieved successful IPOs and “graduated” from the Top 100 list.
Furthermore, according to incomplete statistics from VB100, in 2019 alone, there wereMore than126 institutionsListed companies after the release of the rankingSecuring New Rounds of Financing，More than42 companiesCumulative Number of Listed CompaniesRaised over RMB 500 million in financing, cumulative financing amountOver RMB 65 billion (excluding listed companies)，Total valuation (excluding the overseas list) reached RMB 1,181.77 billionSince its inception, the ranking has become a bellwether for investment in the medical and healthcare sector, guiding development and investment trends in China’s medical and healthcare innovation landscape both currently and in the foreseeable future.
This year, VCBeat has established six major rankings: the China Healthcare Services Ranking, the China Digital Health Ranking, the China Innovative Medical Devices Ranking, the China Innovative Pharmaceuticals Ranking, the China Healthcare Commercial Services Ranking, and the Overseas Innovative Enterprises Ranking.From April 16 to 18, 2021, at the venue of the 5th Future Healthcare 100 Conference, we will announce the final results of the ranking.In addition, the conference positions venture capital and investment relations as one of its core pillars, establishingGlobal Innovation Project Roadshow, Domestic Innovation Project Roadshow, LP-GP Summitand other stages,Optimize Related Interactive Activities, to maximize the connection between enterprises and other sectors with capital.
“Graduated” Companies from Previous Lists
The 5th Future Healthcare Top 100 Conference will, with“The Calculation of Life”as the theme, comprehensively showcasing the innovation ecosystem in China’s healthcare and medical sector, and creating a premier event for the integration of industrial ecosystems.
Conference Time:April 16–18, 2021 (Friday–Sunday), with a view to minimizing concerns about work disruption
Conference Venue:Suzhou · Wujiang
Organizer:VCBeat, VB100, VCBeat Research Institute, VCBeat Orange
Co-organized by:Wujiang District People's Government, Guangdong Province Zhong Nanshan Medical Foundation, China Clinical Research Consortium
Co-organizers:Suzhou Wujiang Dongfang State-owned Capital Investment and Operation Co., Ltd., Smart and Mobile Healthcare Branch of China Medical Device Industry Association, Internet Hospital Branch of Chinese Research Hospital Association
Co-organized by:Yangtze River Delta Integration Demonstration Zone (Suzhou) Venture Capital Service Co., Ltd., Dolphin Internet Medical Industrial Park, UK Beyond Lab, China Digital Therapeutics Alliance (Preparatory), Medlink Consulting Co., Ltd. (China Medlink), UK Global Health Group, Yuanyi Capital, Chuangrui Investment, 5Y Capital, Weilai Capital, Mingfeng Capital, Harvard China Health Association, GeneInsight, Weituo Biotechnology, BoHou Medical
Click the link or scan the QR code to view conference details and purchase tickets.
As of the end of February 2021, spanning6 MonthsThe enterprise submission phase for the 5th “Future Healthcare Top 100” list has successfully concluded, with a cumulative1,000+Corporate Registration Application: Rankings will be determined based on core criteria, including valuations by investment institutions, cumulative financing amounts, corporate growth rates, creditworthiness, and reputation. The corporate rankings and awards have currently entered the stages of information verification and expert review.
Regarding the awards, building on previous editions, we have expanded the award categories and the number of selections. For the first time, individual and institutional awards have been separated. Centered around the two major award programs—the Pengcheng Award and the Weilan Award—we recognize the leadership and innovative vitality driving the development of the healthcare industry. The Weilan Award has newly addedEmerging Entrepreneurs, Emerging InvestorsTwo Major Figure Awards: Identifying Rising Stars from Both the Capital and Industry Sectors Who Represent the Future Direction of Healthcare Development.
All rankings and awards will be announced on-site at the 5th Future Healthcare 100 Conference, held in Wujiang, Jiangsu, from April 16 to 18, 2021. All listed and award-winning companies will be invited to attend the awards gala dinner.
This yearApril 16–18，Suzhou · Wujiang, at the 5th Future Healthcare Top 100 Conference, we will join handsIsrael Chamber of Commerce, UK Beyond Lab, MSQ Fund, Beituo CapitalCo-hosting a global roadshow for innovative healthcare projects, building on the foundation of connecting venture capital stakeholders and empowering healthcare enterprises to engage with leading investment institutions, thereby enriching the international ecosystem for healthcare venture capital dialogue. This global innovation project roadshow will be divided intoInternational Project Roadshow on the 16thandHalf-day Domestic Project Roadshow on the Afternoon of the 15th。
Brief Profiles of Selected Israeli Roadshow Companies
More projects are currently recruiting,We welcome outstanding healthcare innovation projects from both domestic and international markets, as well as investors focused on various sub-sectors of the healthcare industry, to register. The conference will also feature presentations of more high-quality innovative projects from around the world.
April 17,VCBeat, Yangtze River Delta Integration Demonstration Zone (Suzhou) Venture Capital Service Co., Ltd.to be held onSuzhou · Wujiang · Suzhou Bay Oriental Venture Capital BaseCo-hosted the 2021 Future Healthcare Fund LP-GP Summit. As a parallel summit of VCBeat’s 5th Future Healthcare 100 Conference, the 2021 Future Healthcare LP-GP Summit will, on the basis of building a dialogue platform for top-tier healthcare fund partners and leading global health industry enterprises, focus on“Innovation-Driven + Capital-Linked + Self-Evolving”This theme, adopting“Keynote Speech + Roundtable Discussion + Featured Roadshow + Open Networking”interactive format, discussing value creation and value investment in the global healthcare industry.
Partial Confirmed Guests:
(Listed in order of presentation)
Wu Xia| Managing Director, CICC Capital
Xu Hong| Vice President of Qingke Medical
Wang Xiaohui| Managing Partner of Shengjing Jiacheng Fund of Funds
Hu Chuanwei| Vice President of Hengqin Jintou Group
Li Yuhui| Founding Managing Partner, Panlin Capital
Yu Zhengkun| Founding Partner, Jifeng Capital
TangHaofu|Managing Director, Chongqing Dianshi Chuangjian Fund Management
Liu Yu| Managing Partner, BGI Win-Win
Zhou Yi| Partner, SCGC Health Industry Fund
Li Jiangfeng| Partner, Fortune Capital Healthcare Sub-Fund
Marco| Managing Director, Northern Light Venture Capital
Xu Ce| Chief Financial Officer of Genetron Health
Xu Qian| Partner, Detong Capital
Hou Xiaoxi|General Manager, Haier Medical Fund
Wu Aimin|Managing Partner and President, Sinopharm Capital
Li Fan| Partner and Managing Director, Fosun RZ Capital
Zhou Hui| General Manager of Ping An Capital
Special Note: The LP-GP Summit is a closed-door event and requires separate ticket purchase.
In addition, the 5th Future Healthcare Top 100 Conference will optimize the matchmaking and interaction sessions.sessions, fully strengthening communication and connections among investors, entrepreneurs, and other groups at the conference to build deep social networks,Stay tuned.
Click the link or scan the QR code to view conference details and purchase tickets.
Rankings, Roadshows, and LP-GP Summit: For Details, Please Inquire